Please try another search
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of invasive fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Torsten Goesch | 62 | 2021 | Chairman |
Sergey B. Zotchev | - | - | Chief Scientific Officer and Member of Scientific Advisory Panel |
Achim Kaufhold | 65 | 2021 | Independent Board Member |
Henrik Kristian Moltke | 65 | 2021 | Independent Board Member |
Mattias Klintemar | 56 | 2021 | Board Member |
Marianne Kock | 68 | 2021 | Independent Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review